The clinical presentation of CML in lymphoid blast crisis (BC) closely resembles Ph+ ALL, posing diagnostic challenges, particularly when M-BCR rearrangements are present and associated with the p210 protein, which is characteristic of CML [53,55]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.